Clinical Evaluation of Basti along with Rasayana on symptoms of Post COVID-19 Syndrome.Open Labelled Proof of Concept Pragmatic Study.

Government Ayurved College and Hospital0 个研究点目标入组 24 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•Patients of Post COVID-19 Syndrome came under duration of >21 days to 1 year after RTPCR report
•Patient of either sex aged between 18-70 years. irrespective of caste, religion , socio economic and educational status.
•Patient of Post COVID-19 Syndrome having > 20 % ( > 4) of symptoms will be included for the study.
•Patient of Post COVID-19 Syndrome who are willing to participate in trial and ready to give written consent.

•Patients with serious lifethreatening diseases and critically ill patients of Post COVID-19 Syndrome will be excluded.
•Pregnant females and lactating mothers will not be considered for study.
•Basti Anarhya will be excluded for study.
•Patient who have known hypersensitivity reactions to medicines mentioned in the study will be excluded.
•Any other patient which investigator feels not to be included will be excluded from study.

发起方

Government Ayurved College and Hospital